Jing W. Email and Phone Number
An experienced biotech executive with demonstrated versatile and deep expertise in building companies, developing preclinical and clinical stage molecules, raising funding, and negotiating strategic collaborations. A decisive leader with experience in company formation, team and infrastructure building, leading teams with diverse expertise, and operating in a capital efficient manner. Broad experience in business development, strategy & operations, program management, and R&D in biotech and pharmaceutical industries.
-
Vp, Program Leader For SabirnetugAcumen Pharmaceuticals, Inc.Boston, Ma, Us -
Founding Ceo, Coo, President, Board DirectorVigeo Therapeutics Jun 2015 - PresentCambridge, Massachusetts, Us- Cofounded the company in 2015- Oversees fundraising, research and clinical development, business development, and pipeline & program management. - Led the development of lead asset VT1021 from preclinical discovery to registration stage clinical trial in solid tumor indications -
Director Board Of DirectorsEnzymetrics Bioscience, Inc. 2022 - 2024Independent Board DirectorAdvise in fundraising, early-stage company buildup, business development strategy and R&D strategy -
Board AdvisorDeepmed Incorporated China 深药科技(苏州)有限公司 2022 - 2024Advise in fundraising, early-stage company buildup, business development strategy and R&D strategy
-
Global Program Lead, Zenula (Fda Approved) (Tesaro)Gsk Jan 2014 - Dec 2014Brentford, Middlesex, Gb -
Program Leader & Dir Of Portfolio ManagementAlexion Pharmaceuticals, Inc. Jan 2012 - Dec 2013Boston, Massachusetts, Us- led global programs teams to develop therapies for ultra-rare orphan diseases: ALXN1101 for MoCD (Nulibry; FDA approved) ; ALXN1102/1103 for PNH and other indications- led portfolio management and strategic planning functions for Translational Medicine group (Research and Early Development) -
Global Program & Portfolio Lead, Oncology BuNovartis 2009 - 2012Basel, Baselstadt, ChLed multiple global programs from pre-IND to clinical PoC including Tabrecta™ (capmatinib; FDA approved)- Provide strategic and operational leadership- Oversee program budget and strategic directions- Lead cross-functional task forces/sub-teams to establish and ensure alignment across all line functions -
Strategy & Operations, Strategic AlliancesNovartis 2008 - 2009Basel, Baselstadt, ChLed evaluation of in-licensing opportunities for Regenerative Medicine, new indications, and ophthalmology disease area;Led strategic analysis of specific strategy initiatives;Led operational analysis of Novartis deal process -
Head Of Business Development, Novartis Drug Discovery IncubatorNovartis 2005 - 2008Basel, Baselstadt, ChLed all aspects of business development and alliance management activities for the groupProject team head: led two projects in neuromuscular disorders and oncology indications -
Director, Strategic InitiativesChildren'S Hospital Boston 2003 - 2005Boston, Ma, UsEstablished Pediatric Formulation Initiative, which focused on developing pediatric specific clinical development projects;Licensed technologies and raised initial funding for the Initiative;Established partnership with various CROs and collaborators via creative deal structures -
Venture AnalystPuretech Ventures 2002 - 2002Boston, Massachusetts, UsLed evaluation of investment opportunities;Responsible for drafting business plan and fund-raising presentations for incubated start-up company -
Research Fellow, Juvenile Diabetes Foundation International (Jdfi)Joslin Diabetes Center 1998 - 2001Boston, Massachusetts, UsWinner of Best Basic Research Project presented at Endocrine Society annual meeting, 2000 -
Research Fellow, Howard Hughes Medical Institute (Hhmi)Harvard Medical School 1998 - 2001Boston, Ma, Us
Jing W. Skills
Jing W. Education Details
-
Harvard Medical SchoolPost-Doctoral Fellowship -
Jacobs School Of Medicine And Biomedical Sciences At The University At BuffaloPharmacology & Therapeutics -
Northwestern University - Kellogg School Of ManagementFinance & Marketing -
Northwestern University - Kellogg School Of Management -
Peking UniversityPharmacology -
北京四中
Frequently Asked Questions about Jing W.
What company does Jing W. work for?
Jing W. works for Acumen Pharmaceuticals, Inc.
What is Jing W.'s role at the current company?
Jing W.'s current role is VP, program leader for Sabirnetug.
What schools did Jing W. attend?
Jing W. attended Harvard Medical School, Jacobs School Of Medicine And Biomedical Sciences At The University At Buffalo, Northwestern University - Kellogg School Of Management, Northwestern University - Kellogg School Of Management, Peking University, 北京四中.
What skills is Jing W. known for?
Jing W. has skills like Leadership, Research And Development, Clinical Trials, Translational Medicine, Cro, Infectious Diseases, Start Ups, Clinical Research, Ctms, Biotechnology, Regulatory Affairs, Life Sciences.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial